US biotech giant Pfizer will ramp up manufacturing of antimicrobials and precision medicines from its Melbourne site to combat the rising threat of superbugs after tipping $150 million into...
Australia’s MedTech and Pharmaceutical industry growth centre MTPConnect is warning antimicrobial resistant ‘superbugs’ could cause 10,000 deaths annually by 2050 if immediate action to correct a research and development...
The national science agency has partnered with a deep tech incubator to try and build out a local industry for antimicrobial resistance products, warning the pipeline for new “superbug”...